Home Molecular Dx Prenatal/Postnatal Testing

Prenatal/Postnatal Testing

Latest
Stressed black woman crying having personal problems
Prenatal/Postnatal Testing

New Test Helps Find Reasons Couples Experience Multiple Miscarriages

Prenatal genetic screening based on genomic medical technology increasingly allows for the detection and diagnosis of discreet genetic abnormalities within a clinical setting. [Ernesto del Aguila III
Prenatal/Postnatal Testing

New Single-Cell NIPT Lowers Risks, Improves Accuracy in Proof-of-Concept Study

Prenatal/Postnatal Testing

Rady Children’s, Deloitte Study Delivery of Genomic Samples by Drone

Prenatal/Postnatal Testing

ACMG Launches Evidence-Based Guidelines for Genetic, Genomic Testing

Prenatal/Postnatal Testing

NIPT Startup Cradle Genomics Closes $17.1M Series A Financing

Prenatal/Postnatal Testing

Invitae to Expand NIPS Services with Singular Bio Acquisition

passive smoking concept
Prenatal/Postnatal Testing

Secondhand Smoke Increases Unborn Babies’ Risk of Congenital Heart Defects

BGI Genomics plans to commercialize Natera’s Signatera molecular residual disease (MRD) test in China
Prenatal/Postnatal Testing

BGI Genomics to Commercialize Natera’s Signatera Assay in China

PerkinElmer is partnering with Women & Infants Hospital (WIH) of Rhode Island
Prenatal/Postnatal Testing

PerkinElmer, Hospital Partner on Clinical Trial of Vanadis NIPT Platform

Source:Jill Lehmann Photography/Getty Images
Prenatal/Postnatal Testing

Blood Test Identifies Preterm Birth Risk of Expectant Mothers

Load more

New Products

View More
Load more
Copyright © 2020 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up